2023 is fast-approaching and investors are already starting to think about the various ETFs they can choose from to generate returns or hedge the market. One of the most sought after asset classes is pharmaceutical ETFs, which offer exposure to the global pharmaceuticals industry. Pharmaceutical ETFs are a type of exchange-traded funds (ETFs) that focus on the global pharmaceuticals industry, including large drug manufacturers, biotechnology companies, and drug distributors. Pharmaceutical ETFs track a basket of stocks that make up the industry and allow investors to diversify their exposure and make their portfolio more resilient to changes within the larger pharmaceuticals sector. In this article, we’ll take a look at some of the biggest and most popular pharmaceutical ETFs for 2023. Specifically, we’ll be looking at ETFs that offer broad-based, sector-specific, dividend-focused, and value-oriented strategies. The first ETF we’ll consider is the SPDR S&P Pharmaceuticals ETF (XPH). This ETF tracks the S&P Pharmaceuticals Sector Index, which consists of 40 large and mid-capitalization U.S. pharmaceutical companies. If you’re looking to get exposure to a broad range of pharmaceutical companies, XPH is a great choice. Next up is the First Trust NYSE Arca Pharmaceuticals Index Fund (FPH). This ETF provides exposure to 19 of the largest and most liquid pharmaceutical stocks on the NYSE Arca exchange. It tracks the NYSE Arca Pharmaceuticals Index, which includes companies engaged in the research and development, manufacturing, and distribution of either prescription or over-the-counter medications. The Third Avenue Pharmaceuticals and Medical Device Opportunities Fund (TPY) is another popular choice for pharmaceutical investors. This ETF focuses on companies in the medical device and pharmaceutical industries, and its portfolio includes both established and emerging companies. For those looking for a dividend-focused option, the iShares Pharmaceuticals ETF (PILL) is a great choice. This ETF tracks the Dow Jones U.S. Pharmaceuticals Index, which evaluates companies that develop, manufacture, and market ethical, generic, or over-the-counter drugs. PILL currently offers a dividend yield of 2.78%, making it a great option for investors seeking long-term income. Finally, the PowerShares Dynamic Pharmaceuticals Portfolio (PJP) is another ETF that offers exposure to the pharmaceutical industry. This ETF follows an index created and managed by Dynamic, an investment research firm, that tracks large- and mid-capitalization stocks in the pharmaceutical industry. PJP is a great choice if you’re looking for value-oriented investments in the sector. With so many options to choose from, investors now have access to a wide array of ETFs that provide exposure to the pharmaceuticals industry. If you’re looking to diversify or hedge your portfolio in 2023, any of the ETFs mentioned in this article should be considered.